Bimodal-hybrid heterocyclic amine targeting oxidative pathways and copper mis-regulation in Alzheimer's disease
Open Access
- 21 August 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 6 (11) , 2072-2082
Abstract
Oxidative stress resulting from metal-ion misregulation plays a role in the development of Alzheimer’s disease (AD). This process includes the productKeywords
Funding Information
- Welch Foundation (P-1760)
This publication has 46 references indexed in Scilit:
- A potent antioxidant small molecule aimed at targeting metal-based oxidative stress in neurodegenerative disordersChemical Communications, 2013
- Development of Bifunctional Stilbene Derivatives for Targeting and Modulating Metal-Amyloid-β SpeciesInorganic Chemistry, 2011
- Estrogen Protection in Friedreich's Ataxia Skin FibroblastsEndocrinology, 2011
- Minding metals: Tailoring multifunctional chelating agents for neurodegenerative diseaseDalton Transactions, 2009
- Small Molecule Modulators of Copper-Induced Aβ AggregationJournal of the American Chemical Society, 2009
- Aβ-mediated ROS production by Cu ions: Structural insights, mechanisms and relevance to Alzheimer's diseaseBiochimie, 2009
- Effects of Cyclen and Cyclam on Zinc(II)- and Copper(II)-Induced Amyloid β-Peptide Aggregation and NeurotoxicityInorganic Chemistry, 2009
- Lipoic acid significantly restores, in rats, the age‐related decline in vasomotionBritish Journal of Pharmacology, 2008
- Redox Chemistry of Copper–Amyloid‐β: The Generation of Hydroxyl Radical in the Presence of Ascorbate is Linked to Redox‐Potentials and Aggregation StateChemBioChem, 2007
- Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)Chemical Reviews, 2006